Henderson, Nevada – July 15, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application. On July 13 the company and its regulatory consultant met with the full FDA team assigned to review its Class III PMA application. The focus of the meeting was […]
News
United Health Products Announces Settlement of SEC Investigation
Henderson, Nevada – June 16, 2022 – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021. UHP has agreed with the Securities and Exchange Commission (the Commission) to […]
United Health Products Provides Regulatory Update
Henderson, Nevada – May 18, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process. Regulatory Review As previously disclosed, on April 20, 2022, UHP delivered to the U.S. Food & Drug Administration (FDA) a supplemented and e-formatted Premarket Approval (PMA) response for its HemoStyp™ hemostatic […]
Support for Ukraine
In an effort to support the people of Ukraine and those working to defend the country against the Russian invasion, UHP donated 10,000 units of its HemoStyp® hemostatic gauze to aid with much needed civilian and military medical care. United Health Products dropped off the final shipment of 10,000 units of HemoStyp gauze with AFYA, […]
United Health Products Provides Regulatory and Business Update
Henderson, Nevada – April 27, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process and other matters. Regulatory Review As previously disclosed in the company’s Form 10-K, the U.S. Food & Drug Administration (FDA) requested in late January 2022 that i) the responses submitted by UHP […]
United Health Products Provides Regulatory and Business Update
Henderson, Nevada – April 1, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its regulatory process, business condition, and other matters. Regulatory Approvals Following the submission in October, 2021 of a response to the FDA’s questions and comments on its Premarket Approval (PMA) application, UHP and the FDA held […]